184 related articles for article (PubMed ID: 33450747)
21. Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays.
Merker JD; Devereaux K; Iafrate AJ; Kamel-Reid S; Kim AS; Moncur JT; Montgomery SB; Nagarajan R; Portier BP; Routbort MJ; Smail C; Surrey LF; Vasalos P; Lazar AJ; Lindeman NI
Arch Pathol Lab Med; 2019 Apr; 143(4):463-471. PubMed ID: 30376374
[TBL] [Abstract][Full Text] [Related]
22. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.
Peng R; Zhang R; Horan MP; Zhou L; Chai SY; Pillay N; Tay KH; Badrick T; Li J
Oncologist; 2020 Mar; 25(3):218-228. PubMed ID: 32162803
[TBL] [Abstract][Full Text] [Related]
23. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
[TBL] [Abstract][Full Text] [Related]
24. Impact of next generation sequencing results on clinical management in patients with hematological disorders.
Patel BJ; Barot SV; Xie Y; Cook JR; Carraway HE; Hsi ED
Leuk Lymphoma; 2021 Jul; 62(7):1702-1710. PubMed ID: 33533694
[TBL] [Abstract][Full Text] [Related]
25. [NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].
Maeda T
Rinsho Ketsueki; 2022; 63(4):302-307. PubMed ID: 35491220
[TBL] [Abstract][Full Text] [Related]
26. Proficiency testing for bacterial whole genome sequencing: an end-user survey of current capabilities, requirements and priorities.
Moran-Gilad J; Sintchenko V; Pedersen SK; Wolfgang WJ; Pettengill J; Strain E; Hendriksen RS;
BMC Infect Dis; 2015 Apr; 15():174. PubMed ID: 25887164
[TBL] [Abstract][Full Text] [Related]
27. Next-generation sequencing-based panel testing for myeloid neoplasms.
Kuo FC; Dong F
Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
[TBL] [Abstract][Full Text] [Related]
28. Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation.
Davies KD; Farooqi MS; Gruidl M; Hill CE; Woolworth-Hirschhorn J; Jones H; Jones KL; Magliocco A; Mitui M; O'Neill PH; O'Rourke R; Patel NM; Qin D; Ramos E; Rossi MR; Schneider TM; Smith GH; Zhang L; Park JY; Aisner DL
J Mol Diagn; 2016 Jul; 18(4):572-9. PubMed ID: 27155050
[TBL] [Abstract][Full Text] [Related]
29. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
Rosenthal SH; Gerasimova A; Ma C; Li HR; Grupe A; Chong H; Acab A; Smolgovsky A; Owen R; Elzinga C; Chen R; Sugganth D; Freitas T; Graham J; Champion K; Bhattacharya A; Racke F; Lacbawan F
PLoS One; 2021; 16(4):e0243683. PubMed ID: 33909614
[TBL] [Abstract][Full Text] [Related]
30. Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies.
Keegan A; Bridge JA; Lindeman NI; Long TA; Merker JD; Moncur JT; Montgomery ND; Nagarajan R; Rothberg PG; Routbort MJ; Vasalos P; Xian R; Kim AS
Arch Pathol Lab Med; 2020 Jan; ():. PubMed ID: 31986076
[TBL] [Abstract][Full Text] [Related]
31. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
Northrup V; Maybank A; Carson N; Rahmeh T
Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
[TBL] [Abstract][Full Text] [Related]
32. Assuring the Quality of Next-Generation Sequencing in Clinical Microbiology and Public Health Laboratories.
Gargis AS; Kalman L; Lubin IM
J Clin Microbiol; 2016 Dec; 54(12):2857-2865. PubMed ID: 27510831
[TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls.
Maslah N; Verger E; Schlageter MH; Miclea JM; Kiladjian JJ; Giraudier S; Chomienne C; Cassinat B
Ann Hematol; 2019 Jan; 98(1):111-118. PubMed ID: 30259120
[TBL] [Abstract][Full Text] [Related]
34. The Interpretation of Sequence Variants in Myeloid Neoplasms.
Hanbazazh M; Harada S; Reddy V; Mackinnon AC; Harbi D; Morlote D
Am J Clin Pathol; 2021 Oct; 156(5):728-748. PubMed ID: 34155503
[TBL] [Abstract][Full Text] [Related]
35. Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report.
Lee TD; Aisner DL; David MP; Eno CC; Gagan J; Gocke CD; Guseva NV; Haley L; Jajosky AN; Jones D; Mansukhani MM; Mroz P; Murray SS; Newsom KJ; Paulson V; Roy S; Rushton C; Segal JP; Senaratne TN; Siddon AJ; Starostik P; Van Ziffle JAG; Wu D; Xian RR; Yohe S; Kim AS
Blood Adv; 2023 Aug; 7(16):4599-4607. PubMed ID: 37236162
[TBL] [Abstract][Full Text] [Related]
36. In Silico Proficiency Testing for Clinical Next-Generation Sequencing.
Duncavage EJ; Abel HJ; Pfeifer JD
J Mol Diagn; 2017 Jan; 19(1):35-42. PubMed ID: 27863262
[TBL] [Abstract][Full Text] [Related]
37. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
[TBL] [Abstract][Full Text] [Related]
38. Review of Clinical Next-Generation Sequencing.
Yohe S; Thyagarajan B
Arch Pathol Lab Med; 2017 Nov; 141(11):1544-1557. PubMed ID: 28782984
[TBL] [Abstract][Full Text] [Related]
39. Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections.
Yu J; Diaz JD; Goldstein SC; Patel RD; Varela JC; Reyenga C; Smith M; Smith T; Balls J; Ahmad S; Mori S
Transplant Cell Ther; 2021 Jun; 27(6):500.e1-500.e6. PubMed ID: 33849818
[TBL] [Abstract][Full Text] [Related]
40. Next generation sequencing in hematolymphoid neoplasia.
Kuo FC
Semin Hematol; 2019 Jan; 56(1):2-6. PubMed ID: 30573040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
